35188059|t|Broad activation of the PRKN pathway triggers synaptic failure by disrupting synaptic mitochondrial supply in early tauopathy.
35188059|a|Mitochondrial defects are a hallmark of Alzheimer disease (AD), with pathologically phosphorylated MAPT/tau (phospho-MAPT/tau) reported to induce mitochondrial damage. Mitophagy constitutes a key pathway of mitochondrial quality control by which damaged mitochondria are sequestered within autophagosomes for lysosomal degradation. However, the mechanistic understanding of mitophagy and its association with pathologies under tauopathy conditions remains very limited. Here, we reveal that mitochondrial stress under phospho-MAPT/tau-mediated challenges broadly activates PRKN-mediated mitophagy which induces an unexpected effect - depletion of mitochondria from synaptic terminals, a characteristic feature in early tauopathy. PRKN activation accelerates RHOT1 turnover and consequently halts RHOT1-mediated mitochondrial anterograde movement, which disrupts mitochondrial supply to tauopathy synapses and thereby impairs synaptic function. Strikingly, increasing RHOT1 levels prevents synapse loss and reverses cognitive impairment in tauopathy mice by restoring synaptic mitochondrial populations. Thus, our study uncovers an important early mechanism underlying tauopathy-linked synaptic failure and opens a new avenue for specifically targeting early synaptic dysfunction in tauopathies, including AD.Abbreviations: AAV: adeno-associated virus; AD: Alzheimer disease; FTD: Frontotemporal dementia; LTP: long-term potentiation; Deltapsim: mitochondrial membrane potential; Phospho-MAPT/tau: hyperphosphorylated Microtubule Associated Protein Tau/tau; RHOT1: ras homolog family member T1; RNAi: RNA interference; Tg: transgenic.
35188059	24	28	PRKN	Gene	50873
35188059	116	125	tauopathy	Disease	MESH:D024801
35188059	127	148	Mitochondrial defects	Disease	MESH:C565376
35188059	167	184	Alzheimer disease	Disease	MESH:D000544
35188059	186	188	AD	Disease	MESH:D000544
35188059	273	293	mitochondrial damage	Disease	MESH:D028361
35188059	554	563	tauopathy	Disease	MESH:D024801
35188059	700	704	PRKN	Gene	50873
35188059	846	855	tauopathy	Disease	MESH:D024801
35188059	857	861	PRKN	Gene	50873
35188059	885	890	RHOT1	Gene	59040
35188059	923	928	RHOT1	Gene	59040
35188059	1013	1022	tauopathy	Disease	MESH:D024801
35188059	1094	1099	RHOT1	Gene	59040
35188059	1142	1162	cognitive impairment	Disease	MESH:D003072
35188059	1166	1175	tauopathy	Disease	MESH:D024801
35188059	1176	1180	mice	Species	10090
35188059	1295	1304	tauopathy	Disease	MESH:D024801
35188059	1394	1405	dysfunction	Disease	MESH:D006331
35188059	1409	1420	tauopathies	Disease	MESH:D024801
35188059	1432	1448	AD.Abbreviations	Disease	MESH:D000544
35188059	1450	1453	AAV	Species	
35188059	1455	1477	adeno-associated virus	Species	272636
35188059	1479	1481	AD	Disease	MESH:D000544
35188059	1483	1500	Alzheimer disease	Disease	MESH:D000544
35188059	1502	1505	FTD	Disease	MESH:D057180
35188059	1507	1530	Frontotemporal dementia	Disease	MESH:D057180
35188059	1606	1618	Phospho-MAPT	Gene	
35188059	1644	1674	Microtubule Associated Protein	Gene	66302
35188059	1684	1689	RHOT1	Gene	59040
35188059	1691	1719	ras homolog family member T1	Gene	59040
35188059	Association	MESH:D024801	59040
35188059	Association	MESH:D003072	59040
35188059	Association	MESH:D024801	50873
35188059	Association	MESH:D057180	59040
35188059	Association	50873	59040

